The Peptide Knowledge Hub: Evidence, Benefits, Risks and Safety (2026 Guide)
OneDayMD Research Team | Evidence and regulatory review: 16 November 2026 | Independent health research and education Peptides have become one of the most talked-about subjects in modern medicine, regenerative medicine, aesthetics, sports performance and longevity research. From GLP-1 medications for obesity and diabetes to BPC-157 for tissue repair, GHK-Cu for skin health and MOTS-c for metabolic research, interest in peptides is expanding rapidly. But an important question is often overlooked: what do we actually know about these substances, and how much of what is being marketed has been demonstrated in humans? Some peptide-based medicines have transformed clinical care and are supported by extensive randomised controlled trials. Other compounds have demonstrated interesting biological effects in laboratory experiments or animal models but have little or no reliable human evidence. The rapidly growing market has also created concerns about product authenticity, m...